Workers at J.E. Pierce Apothecary, a compounding pharmacy in Brookline. (Curt Nickisch/WBUR) BOSTON A second compounding pharmacy in Massachusetts has agreed to temporarily shut down. Ameridose of Westborough is run by the same executives who run the Framingham company that produced the steroid linked to a deadly outbreak of fungal meningitis. More than 130 people in 11 states have been sickened. Twelve have died. But unlike New England Compounding Center, Ameridose is not issuing recalls while regulators inspect its facility. The investigation into the mounting death toll linked to NECC is prompting many to call for greater regulation of such compounding pharmacies. Still, many in the industry say that will likely only make things worse. Smaller Pharmacies Forced To Adapt Ever since the news broke that a compounding pharmacy in Massachusetts was been linked to a growing roster of dead patients, Greg Laham has been upset. Its really a shame, Laham said. Its a horrible thing. Laham is the owner of a different compounding pharmacy, one of dozens around the state, Sullivans in Roslindale. The store opened the year Fenway Park did 100 years ago. Mr. Sullivan started the business in 1912. Theres been three owners, Laham said. He, another … Continue reading →

The Massachusetts pharmacy linked to a nationwide deadly meningitis outbreak has had their license suspended to distribute prescription drugs in Ohio. The decision comes as Ohio health officials said they have notified nearly every Ohioan who received the recalled steroid suspected in 12 deaths and 137 infections nationally. Kyle Parker, director of the Ohio Board of Pharmacy, announced on Wednesday the summary suspension of the license of New England Compounding Center of Framingham, Mass. In a statement, the state pharmacy board said the suspension was made after discussions with the Ohio Department of Health. The pharmacy board found clear and convincing evidence that the continuation of New England Compounding Centers professional practice presented a danger of immediate and serious harm to others, the statement said. The Centers for Disease Control and Prevention Nationally said all of the people sickened received the epidural steroid injections of allegedly contaminated methylprednisolone acetate compounded by the Massachusetts pharmacy, which has ceased operations since the outbreak was identified. The pharmacy has voluntarily recalled all of its products, including the injectable steroid. Ohio has recorded one rare form of fungal meningitis infection, an unidentified 65-year-old male. The drug was administered to 424 patients through four pain … Continue reading →

Published: Oct. 10, 2012 at 5:26 PM BOSTON, Oct. 10 (UPI) -- Massachusetts officials said an executive of a sister company of the pharmacy linked to the meningitis outbreak recused herself as a state regulator. Sophia Pasedis, vice president of regulatory affairs and compliance at Ameridose, which shares the same owner as that of the New England Compounding Center in Framingham, Mass., was appointed to the 11-member Massachusetts Board of Registration in Pharmacy in June 2004 and reappointed in 2008, The Boston Globe reported. The New England Compounding Center is at the center of the fungal meningitis outbreak that has killed 12 and sickened 137 in 10 states. The compounding pharmacy in Framingham, Mass., produced about 13,000 doses of the injectable steroid methylprednisolone acetate used to treat back pain. The investigation into the exact cause of the outbreak is ongoing locally and nationally. The Centers for Disease Control and Prevention in Atlanta said its preliminary analyses showed all infected patients received an injection of preservative-free methylprednisolone acetate, a steroid prepared by the New England Compounding Center. "The compounding center voluntarily surrendered its license at the request of the state of Massachusetts and at the direction of public health officials, announced … Continue reading →

The pharmacy responsible for manufacturing contaminated steroid shots suspected in a meningitis outbreak, which has killed 12 and sickened more than 120 around the U.S., has set up a recall operations center to properly remove its products from circulation. Since the September 25 recall of three lots of a steroid produced by the New England Compounding Center (NECC), the outbreak has spread to 10 states and infected 137 people, according to state health departments and the Centers for Disease Control and Prevention Brad Puffer, director of communications for the office of Massachusetts Attorney General Martha Coakley, said he could not "confirm or deny" a criminal investigation into the company. Also of interest one of the NECCs owners, Sophia Pasedis, also owns a related pharmacy nearby; one of its executives is a board member and former president of the state agency that regulates pharmacies. The Boston Globe reported that Sophia Pasedis was appointed to the 11-member Massachusetts Board of Registration in Pharmacy in both 2004 and 2008. She also serves as the vice president of regulatory affairs and compliance at Ameridose in Westborough which has the same ownership as the Framingham-based NECC. The state Public Health Department, which oversees the pharmacy … Continue reading →

NEW YORK, Oct. 11, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: http://www.reportlinker.com/p096626/Pharmacy-Automation-Technologies-and-Global-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmacies_and_Drug_Stores REPORT HIGHLIGHTS -The global market for pharmacy automation increased from $2.1 billion in 2006 to $2.3 billion in 2007. It should reach $3.6 billion by 2012, a compound annual growth rate (CAGR) of 9.4%.-By 2012, the inpatient pharmacy automation market is expected to be worth nearly $2.9 billion, a CAGR of 9.8%.-The outpatient pharmacy automation segment will continue to experience moderate growth through 2012, with a CAGR of 7.8% over the next 5 years. INTRODUCTION Although pharmacy automation dates back to the 1970s with the introduction of pill counting machines, the pharmacy automation market is anticipated to make generous strides in technology and efficiency through the forecast period outlined in this study. The continually increasing demand for accuracy, safety, industry standards, and competency in the pharmacy environment by regulatory authorities, manufacturers, healthcare professionals, and consumers has forced the growth of this market. New opportunities in various settings will continue to surface-from small, private, family-owned pharmacies to large hospital and mail-order service facilities, such as Medco Health Solutions, Inc. Many small, private pharmacies are still conducting operations through manual and … Continue reading →